Pheochromocytoma in multiple endocrine neoplasia type 2: European study

Modigliani, E; F. A. Vasen, Hans; D. Raue, Kristen; Dralle, Henning; Frilling, Andrea; G. Gheri, R.; Luisa Brandi, Maria; Limbert, Edward; Niederle, Bruno; FORGAS, L.; Rosenberg‐Bourgin, Myriam; Calmettes, C; EUROMEN STUDY GROUP, THE

doi:10.1111/j.1365-2796.1995.tb01211.x

Public

Pheochromocytoma in multiple endocrine neoplasia type 2: European study

Published in Journal of Internal Medicine • Oct 1, 1995

Authors:

E Modigliani

Hans F. A. Vasen

Kristen D. Raue

Abstract

OBJECTIVES: Pheochromocytoma (pheo) is the second component of the multiple endocrine neoplasia type 2 (MEN 2) syndrome. Clinical expression is sometimes poor, and chronology between medullary thyroid carcinoma (MTC) and pheo is not well evaluated. Therefore, a retrospective study was done in eight ...

Subject

Medicine

Pheochromocytoma

Multiple endocrine neoplasia

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!